Synapse

← Chinese Medical Journal - Pulmonary and Critical Care Medicine

Papers in Chinese Medical Journal - Pulmonary and Critical Care Medicine

Page 1 · newest first

  1. Adoptive cell therapy in lung cancer: progress, challenges, and prospectsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  2. Advances in metabolic reprogramming of pulmonary fibrosisChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  3. Trends in lung cancer burden, risk factors, and disease projections in China and the United States, 1990–2023Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  4. Therapeutic vaccines for NSCLC: From mechanisms to clinical translationChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  5. Treatable traits-based management of bronchiectasis: moving from theory to clinical practiceChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  6. Prevalence of anxiety and depression and diagnostic utility of the CAT scale in spirometry-confirmed COPD patients: Findings from the Chinese Population Health and Multimorbidities StudyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  7. Structural and cellular mechanisms of airway mucus plugging in the larger airwaysChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  8. Respiratory microbiota transplantation: optimized framework and its impact on metabolic and immune characteristicsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  9. UBE2M deficiency in alveolar macrophages promotes emphysema through HIF-2α/MMP12 axisChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  10. Molecular mechanisms and therapeutic targets in lung cancer–nerve crosstalkChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  11. Artificial intelligence in respiratory medicine: From diagnosis to treatment and future directionsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  12. Circadian rhythms and lung cancer biology and immunotherapy: Emerging opportunities and challengesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  13. Asthma endotypes and theratypesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  14. Immunotherapy for patients with EGFR-TKI-resistant non-small-cell lung cancer: Potential mechanisms, efficacy predictors, and therapeutic integrationChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  15. Incidence of acute exacerbation and its related factors among chronic obstructive pulmonary disease patients aged 40 years and older in ChinaChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  16. Progression of interstitial lung abnormalities and its impact on mortality in patients with lung cancer resectionChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  17. Nanovaccines for lung cancer: Platforms, mechanistic insights, and translational challengesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  18. Trained immunity in respiratory diseases: Mechanisms of action and intervention strategiesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2026
  19. CAR-T therapy: Advances in respiratory diseasesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  20. Type 2 inflammation in chronic obstructive pulmonary disease: A promising treatable trait and practice recommendationsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  21. Global, regional, and national burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2023, and projections to 2050: A systematic analysis for the Global Burden of Disease Study 2023Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  22. Enrichment of the commensal microbiome in the lower respiratory tract is associated with improved outcomes following lung transplantationChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  23. Skin-lung axis in the atopic march: The immune link from skin to lungsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  24. Aging and lung diseases: Unraveling mechanisms and therapeutic targetsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  25. Burden of non-COVID-19 lower respiratory infections and etiologies in China and globally: An analysis for the global burden of disease study 2021Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  26. Mechanisms and current advances in treating KRAS-mutated lung cancerChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  27. The value of treatable traits across the spectrum of adult asthma severityChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  28. Unraveling the mechanisms of virus-induced asthma exacerbation: epithelial injury, immune dysregulation, and novel interventionsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  29. Burden of chemotherapy-induced myelosuppression (CIM) in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A retrospective real-world studyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  30. Temporal trends in the burden of tracheal, bronchial, and lung cancer in China and globally: A comprehensive analysis from 1990 to 2021Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  31. Achieving remission in severe asthmaChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  32. Burden of chronic obstructive pulmonary disease and risk factors in China from 1990 to 2021: Analysis of global burden of disease 2021Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  33. Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapiesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  34. Burden of chronic respiratory diseases and their attributable risk factors in 204 countries and territories, 1990–2021: Results from the global burden of disease study 2021Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  35. Clinical characteristics of patients with positive fungal pathogens during acute exacerbation of chronic obstructive pulmonary disease: A retrospective studyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  36. Advances in idiopathic pulmonary fibrosis diagnosis and treatmentChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  37. Unraveling tumoral heterogeneity and angiogenesis-associated mechanisms of PD-1 and LAG-3 dual inhibition in lung cancers by single-cell RNA sequencingChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  38. Pulmonary embolism prophylaxis and treatment: What's right, what's wrong, and the futureChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  39. Clinical management of checkpoint inhibitor pneumonitis: Focus, challenges, and future directionsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  40. Global, regional, and national burden of asthma from 1990 to 2021: A systematic analysis of the global burden of disease study 2021Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  41. Advances in pathophysiology and assessment methods of chronic obstructive pulmonary disease with frailtyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  42. Treatment of allergic bronchopulmonary aspergillosis with biologicsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2025
  43. Neoadjuvant immunotherapy for non-small cell lung cancer: Opportunities and challengesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  44. Lung-resident lymphocytes and their roles in respiratory infections and chronic respiratory diseasesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  45. cGAS-STING signaling pathway in lung cancer: Regulation on antitumor immunity and application in immunotherapyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  46. Role of GLCCI1 in inhibiting PI3K-induced NLRP3 inflammasome activation in asthmaChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  47. Parkin deficiency aggravates inflammation-induced acute lung injury by promoting necroptosis in alveolar type II cellsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  48. When prenatal infection meets postnatal hyperoxia: Better models for bronchopulmonary dysplasia and its therapeutic approachesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  49. Heterogeneity and therapeutic implications of cancer-associated fibroblasts in lung cancer: Recent advances and future perspectivesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  50. Advances in the awareness of tuberculosis-associated chronic obstructive pulmonary diseaseChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024